Endonovo Therapeutics Stock Market Value
| ENDV Stock | USD 0.0007 0.0001 12.50% |
| Symbol | Endonovo |
Endonovo Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Endonovo Therapeutics' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Endonovo Therapeutics.
| 11/02/2024 |
| 12/02/2024 |
If you would invest 0.00 in Endonovo Therapeutics on November 2, 2024 and sell it all today you would earn a total of 0.00 from holding Endonovo Therapeutics or generate 0.0% return on investment in Endonovo Therapeutics over 30 days. Endonovo Therapeutics is related to or competes with Bio Path, Cingulate, Purple Biotech, Soleno Therapeutics, Genelux Common, Dyadic International, and Monopar Therapeutics. Endonovo Therapeutics, Inc., a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutic... More
Endonovo Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Endonovo Therapeutics' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Endonovo Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 67.27 | |||
| Value At Risk | (20.00) | |||
| Potential Upside | 12.5 |
Endonovo Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Endonovo Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Endonovo Therapeutics' standard deviation. In reality, there are many statistical measures that can use Endonovo Therapeutics historical prices to predict the future Endonovo Therapeutics' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.64) | |||
| Total Risk Alpha | (2.33) | |||
| Treynor Ratio | 2.6 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Endonovo Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Endonovo Therapeutics Backtested Returns
Endonovo Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0364, which denotes the company had a -0.0364% return per unit of standard deviation over the last 3 months. Endonovo Therapeutics exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Endonovo Therapeutics' Mean Deviation of 5.86, coefficient of variation of (1,487), and Standard Deviation of 9.9 to check the risk estimate we provide. The firm shows a Beta (market volatility) of -0.26, which means not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Endonovo Therapeutics are expected to decrease at a much lower rate. During the bear market, Endonovo Therapeutics is likely to outperform the market. At this point, Endonovo Therapeutics has a negative expected return of -0.36%. Please make sure to confirm Endonovo Therapeutics' information ratio, as well as the relationship between the skewness and day typical price , to decide if Endonovo Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.63 |
Good predictability
Endonovo Therapeutics has good predictability. Overlapping area represents the amount of predictability between Endonovo Therapeutics time series from 2nd of November 2024 to 17th of November 2024 and 17th of November 2024 to 2nd of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Endonovo Therapeutics price movement. The serial correlation of 0.63 indicates that roughly 63.0% of current Endonovo Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.63 | |
| Spearman Rank Test | 0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Endonovo Therapeutics lagged returns against current returns
Autocorrelation, which is Endonovo Therapeutics pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Endonovo Therapeutics' pink sheet expected returns. We can calculate the autocorrelation of Endonovo Therapeutics returns to help us make a trade decision. For example, suppose you find that Endonovo Therapeutics has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Endonovo Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Endonovo Therapeutics pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Endonovo Therapeutics pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Endonovo Therapeutics pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Endonovo Therapeutics Lagged Returns
When evaluating Endonovo Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Endonovo Therapeutics pink sheet have on its future price. Endonovo Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Endonovo Therapeutics autocorrelation shows the relationship between Endonovo Therapeutics pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Endonovo Therapeutics.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Endonovo Pink Sheet Analysis
When running Endonovo Therapeutics' price analysis, check to measure Endonovo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Endonovo Therapeutics is operating at the current time. Most of Endonovo Therapeutics' value examination focuses on studying past and present price action to predict the probability of Endonovo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Endonovo Therapeutics' price. Additionally, you may evaluate how the addition of Endonovo Therapeutics to your portfolios can decrease your overall portfolio volatility.